Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nony

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Circulation|May 23, 2001
Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosisL Pinede, J Ninet, P Duhaut, et al.
Therapie|February 10, 2000
[Outline of the problem of indices of therapeutic efficacy. 4. Expression of efficacy when the underlying illness is incurable. Study Group for the Indices of Efficacy]J P Boissel, M Cucherat, G Chatellier, et al.
Cardiology|March 1, 1996
Heterogeneous effect of quinidine on the ventricular depolarization process assessed by the spatial velocity electrocardiogram of the QRS complex. Preliminary report of a new investigative methodS Fareh, P Arnaud, J Fayn, et al.
Therapie|February 10, 2000
[The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use]J P Boissel, M Cucherat, W Li, et al.
In Silico Biology|June 30, 2020
Dynamical modeling of pro- and anti-inflammatory cytokines in the early stage of septic shockJ Tallon, B Browning, F Couenne, et al.
Therapie|September 29, 1999
[The problem of therapeutic efficacy indices. 2. Description of the indices]J P Boissel, M Buyse, M Cucherat, et al.
Therapie|July 8, 1999
[The problem of therapeutic efficacy indices. 1. Elements of the problem]J P Boissel, M Cucherat, F Gueyffier, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2000
In vivo measurement of myocardial oxidative metabolism and blood flow does not show changes in cancer patients undergoing doxorubicin therapyP Nony, J P Guastalla, P Rebattu, et al.
Journal of Cardiovascular Pharmacology|October 1, 1993
Electrophysiologic effects of a potassium channel activator (pinacidil) on repolarization parameters in healthy volunteers: a surface ECG studyP Nony, P Girard, P Arnaud, et al.
Experimental Neurology|June 2, 2016
Dynamic changes of depolarizing GABA in a computational model of epileptogenic brain: Insight for Dravet syndromeP Kurbatova, F Wendling, A Kaminska, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Circulation|May 23, 2001
Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosisL Pinede, J Ninet, P Duhaut, et al.
Therapie|February 10, 2000
[Outline of the problem of indices of therapeutic efficacy. 4. Expression of efficacy when the underlying illness is incurable. Study Group for the Indices of Efficacy]J P Boissel, M Cucherat, G Chatellier, et al.
Cardiology|March 1, 1996
Heterogeneous effect of quinidine on the ventricular depolarization process assessed by the spatial velocity electrocardiogram of the QRS complex. Preliminary report of a new investigative methodS Fareh, P Arnaud, J Fayn, et al.
Therapie|February 10, 2000
[The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use]J P Boissel, M Cucherat, W Li, et al.
In Silico Biology|June 30, 2020
Dynamical modeling of pro- and anti-inflammatory cytokines in the early stage of septic shockJ Tallon, B Browning, F Couenne, et al.
Therapie|September 29, 1999
[The problem of therapeutic efficacy indices. 2. Description of the indices]J P Boissel, M Buyse, M Cucherat, et al.
Therapie|July 8, 1999
[The problem of therapeutic efficacy indices. 1. Elements of the problem]J P Boissel, M Cucherat, F Gueyffier, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2000
In vivo measurement of myocardial oxidative metabolism and blood flow does not show changes in cancer patients undergoing doxorubicin therapyP Nony, J P Guastalla, P Rebattu, et al.
Journal of Cardiovascular Pharmacology|October 1, 1993
Electrophysiologic effects of a potassium channel activator (pinacidil) on repolarization parameters in healthy volunteers: a surface ECG studyP Nony, P Girard, P Arnaud, et al.
Experimental Neurology|June 2, 2016
Dynamic changes of depolarizing GABA in a computational model of epileptogenic brain: Insight for Dravet syndromeP Kurbatova, F Wendling, A Kaminska, et al.
Pageof 7